Asset Details
Do you wish to reserve the book?
A Mouse Model of Multiple System Atrophy: Bench to Bedside
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Mouse Model of Multiple System Atrophy: Bench to Bedside
Do you wish to request the book?
A Mouse Model of Multiple System Atrophy: Bench to Bedside
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A Mouse Model of Multiple System Atrophy: Bench to Bedside
2023
Overview
Multiple system atrophy (MSA) is a rare neurodegenerative disorder with unclear etiology, currently difficult and delayed diagnosis, and rapid progression, leading to disability and lethality within 6 to 9 years after symptom onset. The neuropathology of MSA classifies the disease in the group of a-synucleinopathies together with Parkinson's disease and other Lewy body disorders, but features specific oligodendroglial inclusions, which are pathognomonic for MSA. MSA has no efficient therapy to date. Development of experimental models is crucial to elucidate the disease mechanisms in progression and to provide a tool for preclinical screening of putative therapies for MSA. In vitro and in vivo models, based on selective neurotoxicity, a-synuclein oligodendroglial overexpression, and strain-specific propagation of a-synuclein fibrils, have been developed, reflecting various facets of MSA pathology. Over the years, the continuous exchange from bench to bedside and backward has been crucial for the advancing of MSA modelling, elucidating MSA pathogenic pathways, and understanding the existing translational gap to successful clinical trials in MSA. The review discusses specifically advantages and limitations of the PLP-a-syn mouse model of MSA, which recapitulates motor and non-motor features of the human disease with underlying striatonigral degeneration, degeneration of autonomic centers, and sensitized olivopontocerebellar system, strikingly mirroring human MSA pathology.
Publisher
Elsevier Inc,Springer International Publishing,Springer Nature B.V
Subject
/ alpha-Synuclein - metabolism
/ Animals
/ Atrophy
/ Biomedical and Life Sciences
/ Brain
/ Etiology
/ Fibrils
/ Humans
/ Mice
/ Multiple System Atrophy - epidemiology
/ Multiple System Atrophy - genetics
/ Multiple System Atrophy - physiopathology
/ Multiple System Atrophy - therapy
/ Oligodendroglia - metabolism
/ Review
/ Therapy
